Can-Fite Biopharma Ltd Sponsore

Historical 13F Holders

Symbol
CANF
CUSIP
13471N300
All holders as of
Q4 2025
Type
Equity
Class
SPONSORED ADR
Reported Value, Excluding Options
Total Shares Held, Excluding Options
Total Filers

13D/G Filers

Each filer's latest filing for 13471N300 since 12/18/2024, largest first.

Filer % of Class Filed
Under 5%, checked the "5 percent or less" box, or amended by a later filing (2)
Armistice Capital, LLC 13G/A
4.99% 2/14/2025
Event 12/31/2024
Orca Capital AG 13G/A 4.1% 4/23/2025
Event 4/22/2025

13F Holders by Quarter

Period Filers Shares, Excl. Options Value, Excl. Options
2025 Q4 16 602 k $272 k
2025 Q3 17 1.54 M $954 k
2025 Q2 17 905 k $950 k
2025 Q1 16 134 k $198 k
2024 Q4 15 117 k $190 k
2024 Q3 13 754 k $1.52 M
2024 Q2 12 696 k $1.79 M
2024 Q1 9 589 k $1.31 M
2023 Q4 10 290 k $638 k
2023 Q3 10 67.7 k $179 k
2023 Q2 8 54.6 k $168 k
2023 Q1 9 368 k $844 k